Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $2.34M | ﹤0.01% |
114,900
+15,100
| +15% | +$307K |
|
|
CSW
1627
CSW Industrials
CSW
$5.65B
| $2.34M | ﹤0.01% |
33,849
+4,700
| +16% | +$317K |
|
1628
Universal Corp
UVV
$1.13B
| $2.34M | ﹤0.01% |
55,000
+6,900
| +14% | +$303K |
|
|
BBBY
1629
Bed Bath & Beyond
BBBY
$423M
| $2.34M | ﹤0.01% |
90,420
+24,233
| +37% | +$356K |
|
|
GTY
1630
Getty Realty Corp
GTY
$2.04B
| $2.33M | ﹤0.01% |
78,509
+10,600
| +16% | +$281K |
|
1631
PBF Energy
PBF
$8.81B
| $2.33M | ﹤0.01% |
227,300
+6,500
| +3% | +$65K |
|
|
SWCH
1632
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.32M | ﹤0.01% |
130,300
+17,100
| +15% | +$299K |
|
|
UHT
1633
Universal Health Realty Income Trust
UHT
$573M
| $2.32M | ﹤0.01% |
29,200
+3,900
| +15% | +$367K |
|
|
SGMO
1634
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.32M | ﹤0.01% |
258,760
+33,900
| +15% | +$315K |
|
|
GMS
1635
DELISTED
GMS Inc
GMS
| $2.32M | ﹤0.01% |
94,200
+13,400
| +17% | +$255K |
|
1636
Park National Corp
PRK
$3.72B
| $2.32M | ﹤0.01% |
32,900
+4,400
| +15% | +$322K |
|
1637
Alamo Group
ALG
$2.01B
| $2.31M | ﹤0.01% |
22,500
+3,000
| +15% | +$288K |
|
1638
US Physical Therapy
USPH
$1.22B
| $2.31M | ﹤0.01% |
28,500
+3,700
| +15% | +$270K |
|
1639
Mativ Holdings
MATV
$690M
| $2.31M | ﹤0.01% |
69,000
+9,100
| +15% | +$274K |
|
1640
Marten Transport
MRTN
$1.22B
| $2.3M | ﹤0.01% |
137,375
+18,000
| +15% | +$283K |
|
|
APHA
1641
DELISTED
Aphria Inc. Common Shares
APHA
| $2.3M | ﹤0.01% |
540,500
+75,400
| +16% | +$289K |
|
1642
Goosehead Insurance
GSHD
$2.33B
| $2.3M | ﹤0.01% |
30,600
+5,500
| +22% | +$319K |
|
1643
Mesa Laboratories
MLAB
$631M
| $2.3M | ﹤0.01% |
10,602
+3,000
| +39% | +$691K |
|
1644
Eagle Bancorp
EGBN
$877M
| $2.29M | ﹤0.01% |
70,032
+8,200
| +13% | +$262K |
|
1645
Virgin Galactic
SPCE
$475M
| $2.29M | ﹤0.01% |
+7,020
| New | +$2.31M |
|
|
SCS
1646
DELISTED
Steelcase
SCS
| $2.29M | ﹤0.01% |
189,700
+17,400
| +10% | +$190K |
|
|
WIRE
1647
DELISTED
Encore Wire Corp
WIRE
| $2.29M | ﹤0.01% |
46,833
+6,200
| +15% | +$285K |
|
1648
OceanFirst Financial
OCFC
$1.85B
| $2.25M | ﹤0.01% |
127,833
+16,200
| +15% | +$259K |
|
1649
PJT Partners
PJT
$4.36B
| $2.25M | ﹤0.01% |
43,835
+3,500
| +9% | +$173K |
|
1650
Laureate Education
LAUR
$5.1B
| $2.24M | ﹤0.01% |
224,900
+1,900
| +0.9% | +$18.4K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.